SN Patel, A Shi, TD Wibbelsman… - Therapeutic advances …, 2020 - journals.sagepub.com
The development of ultra-widefield retinal imaging has accelerated our understanding of common retinal diseases. As we continue to validate the diagnostic and prognostic …
The high prevalence of cardiovascular disease particularly in the elderly population is associated with retinal vascular disease. Retinal vein occlusions represent severe …
M Khayat, M Williams, N Lois - Survey of ophthalmology, 2018 - Elsevier
Retinal vein occlusion (RVO)-including central RVO, branch RVO, and hemicentral and hemispheric RVO—is the second most common vascular cause of visual loss, surpassed …
S Sangroongruangsri, T Ratanapakorn… - Expert review of …, 2018 - Taylor & Francis
Introduction: Anti-vascular endothelial growth factor (VEGF) therapy has become the most commonly used treatment for macular edema secondary to retinal vein occlusion (RVO) …
CJ Flaxel, RA Adelman, ST Bailey, A Fawzi, JI Lim… - …, 2020 - aaojournal.org
Background: Retinal vein occlusion (RVO) occurs when there is partial or complete obstruction of a retinal vein, and it is classified by the location of the occlusion. An …
J Li, YM Paulus, Y Shuai, W Fang, Q Liu… - Journal of …, 2017 - Wiley Online Library
For years, branch retinal vein occlusion is still a controversial disease in many aspects. An increasing amount of data is available regarding classification, pathogenesis, risk factors …
Purpose To evaluate the available evidence on the ocular safety and efficacy of current therapeutic alternatives for the management of macular edema (ME) secondary to branch …
TA Mir, S Kherani, G Hafiz, AW Scott, I Zimmer-Galler… - Ophthalmology, 2016 - Elsevier
Purpose To assess changes in retinal nonperfusion (RNP) in patients with retinal vein occlusion (RVO) treated with ranibizumab. Design Secondary outcome measure in …